These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25388299)

  • 21. The Mizon-Richard encompassing test for the Cox and Aalen additive hazards models.
    Martinussen T; Aalen OO; Scheike TH
    Biometrics; 2008 Mar; 64(1):164-71. PubMed ID: 17608786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sieve estimation in semiparametric modeling of longitudinal data with informative observation times.
    Zhao X; Deng S; Liu L; Liu L
    Biostatistics; 2014 Jan; 15(1):140-53. PubMed ID: 24085596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semiparametric additive marginal regression models for multiple type recurrent events.
    Chen X; Wang Q; Cai J; Shankar V
    Lifetime Data Anal; 2012 Oct; 18(4):504-27. PubMed ID: 22899088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling zero-inflated count data when exposure varies: With an application to tumor counts.
    Baetschmann G; Winkelmann R
    Biom J; 2013 Sep; 55(5):679-86. PubMed ID: 24003010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonparametric modeling of the gap time in recurrent event data.
    Du P
    Lifetime Data Anal; 2009 Jun; 15(2):256-77. PubMed ID: 19123038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Additive-multiplicative rates model for recurrent events.
    Liu Y; Wu Y; Cai J; Zhou H
    Lifetime Data Anal; 2010 Jul; 16(3):353-73. PubMed ID: 20229314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Semiparametric modelling and estimation of covariate-adjusted dependence between bivariate recurrent events.
    Ning J; Cai C; Chen Y; Huang X; Wang MC
    Biometrics; 2020 Dec; 76(4):1229-1239. PubMed ID: 31994170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. External validation of European Organization for Research and Treatment of Cancer and Spanish Urological Club for Oncological Treatment scoring models to predict recurrence and progression in Japanese patients with non-muscle invasive bladder cancer treated with bacillus Calmette-Guérin.
    Kohjimoto Y; Kusumoto H; Nishizawa S; Kikkawa K; Kodama Y; Ko M; Matsumura N; Hara I
    Int J Urol; 2014 Dec; 21(12):1201-7. PubMed ID: 25074295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of intravesical bacillus Calmette-Guerin in the treatment of patients with pT1 stage non-muscle-invasive bladder cancer.
    Ajili F; Darouiche A; Chebil M; Boubaker S
    Ultrastruct Pathol; 2013 Aug; 37(4):278-83. PubMed ID: 23789613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smoothing spline ANOVA frailty model for recurrent event data.
    Du P; Jiang Y; Wang Y
    Biometrics; 2011 Dec; 67(4):1330-9. PubMed ID: 21457192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. General joint frailty model for recurrent event data with a dependent terminal event: Application to follicular lymphoma data.
    Mazroui Y; Mathoulin-Pelissier S; Soubeyran P; Rondeau V
    Stat Med; 2012 May; 31(11-12):1162-76. PubMed ID: 22307954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of mitomycin as prophylaxis following endoscopic resection of superficial bladder cancer.
    Huland H; Otto U
    Urology; 1985 Oct; 26(4 Suppl):32-5. PubMed ID: 4049627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chemoprophylaxis of superficial tumors of the bladder with thiotepa: long-term results].
    Durán R; Reina GR; Hontoria JM; Merino C; Olivier C; Carballido J
    Actas Urol Esp; 1989; 13(1):19-23. PubMed ID: 2496583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model.
    Fernandez-Gomez J; Madero R; Solsona E; Unda M; Martinez-Piñeiro L; Gonzalez M; Portillo J; Ojea A; Pertusa C; Rodriguez-Molina J; Camacho JE; Rabadan M; Astobieta A; Montesinos M; Isorna S; Muntañola P; Gimeno A; Blas M; Martinez-Piñeiro JA
    J Urol; 2009 Nov; 182(5):2195-203. PubMed ID: 19758621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential combination of mitomycin C plus bacillus Calmette-Guérin (BCG) is more effective but more toxic than BCG alone in patients with non-muscle-invasive bladder cancer in intermediate- and high-risk patients: final outcome of CUETO 93009, a randomized prospective trial.
    Solsona E; Madero R; Chantada V; Fernandez JM; Zabala JA; Portillo JA; Alonso JM; Astobieta A; Unda M; Martinez-Piñeiro L; Rabadan M; Ojea A; Rodriguez-Molina J; Beardo P; Muntañola P; Gomez M; Montesinos M; Martinez Piñeiro JA;
    Eur Urol; 2015 Mar; 67(3):508-16. PubMed ID: 25301758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials.
    Fernandez-Gomez J; Solsona E; Unda M; Martinez-Piñeiro L; Gonzalez M; Hernandez R; Madero R; Ojea A; Pertusa C; Rodriguez-Molina J; Camacho JE; Isorna S; Rabadan M; Astobieta A; Montesinos M; Muntañola P; Gimeno A; Blas M; Martinez-Piñeiro JA;
    Eur Urol; 2008 May; 53(5):992-1001. PubMed ID: 17950987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic semiparametric transformation models for recurrent event data with a terminal event.
    Jin J; Song X; Sun L
    Stat Med; 2022 Nov; 41(27):5432-5447. PubMed ID: 36121319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A semiparametric additive rate model for a modulated renewal process.
    Chen X; Ding J; Sun L
    Lifetime Data Anal; 2018 Oct; 24(4):675-698. PubMed ID: 29185212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911.
    Oddens JR; Sylvester RJ; Brausi MA; Kirkels WJ; van de Beek C; van Andel G; de Reijke TM; Prescott S; Witjes JA; Oosterlinck W
    Eur Urol; 2014 Oct; 66(4):694-701. PubMed ID: 24948466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.